Fulgent Genetics (FLGT) Competitors $17.23 -0.13 (-0.72%) As of 01:15 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock FLGT vs. PGNY, ADUS, AGL, ARDT, NHC, PACS, TDOC, VRDN, AHCO, and CDNAShould you be buying Fulgent Genetics stock or one of its competitors? The main competitors of Fulgent Genetics include Progyny (PGNY), Addus HomeCare (ADUS), agilon health (AGL), Ardent Health Partners (ARDT), National HealthCare (NHC), PACS Group (PACS), Teladoc Health (TDOC), Viridian Therapeutics (VRDN), AdaptHealth (AHCO), and CareDx (CDNA). These companies are all part of the "healthcare" industry. Fulgent Genetics vs. Progyny Addus HomeCare agilon health Ardent Health Partners National HealthCare PACS Group Teladoc Health Viridian Therapeutics AdaptHealth CareDx Progyny (NASDAQ:PGNY) and Fulgent Genetics (NASDAQ:FLGT) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, community ranking, valuation, analyst recommendations, risk, media sentiment, institutional ownership, earnings and profitability. Does the MarketBeat Community favor PGNY or FLGT? Fulgent Genetics received 142 more outperform votes than Progyny when rated by MarketBeat users. However, 70.83% of users gave Progyny an outperform vote while only 59.80% of users gave Fulgent Genetics an outperform vote. CompanyUnderperformOutperformProgynyOutperform Votes10270.83% Underperform Votes4229.17% Fulgent GeneticsOutperform Votes24459.80% Underperform Votes16440.20% Does the media refer more to PGNY or FLGT? In the previous week, Progyny had 3 more articles in the media than Fulgent Genetics. MarketBeat recorded 9 mentions for Progyny and 6 mentions for Fulgent Genetics. Progyny's average media sentiment score of 1.62 beat Fulgent Genetics' score of 1.45 indicating that Progyny is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Progyny 7 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Fulgent Genetics 3 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk & volatility, PGNY or FLGT? Progyny has a beta of 1.33, indicating that its stock price is 33% more volatile than the S&P 500. Comparatively, Fulgent Genetics has a beta of 1.36, indicating that its stock price is 36% more volatile than the S&P 500. Which has higher earnings and valuation, PGNY or FLGT? Progyny has higher revenue and earnings than Fulgent Genetics. Fulgent Genetics is trading at a lower price-to-earnings ratio than Progyny, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioProgyny$1.17B1.68$62.04M$0.5740.07Fulgent Genetics$283.47M1.89-$167.82M-$1.41-12.30 Do analysts rate PGNY or FLGT? Progyny presently has a consensus target price of $23.64, indicating a potential upside of 3.49%. Fulgent Genetics has a consensus target price of $16.00, indicating a potential downside of 7.78%. Given Progyny's stronger consensus rating and higher probable upside, equities research analysts clearly believe Progyny is more favorable than Fulgent Genetics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Progyny 0 Sell rating(s) 8 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.38Fulgent Genetics 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Is PGNY or FLGT more profitable? Progyny has a net margin of 5.03% compared to Fulgent Genetics' net margin of -59.39%. Progyny's return on equity of 11.36% beat Fulgent Genetics' return on equity.Company Net Margins Return on Equity Return on Assets Progyny5.03% 11.36% 7.87% Fulgent Genetics -59.39%-1.81%-1.66% Do institutionals & insiders have more ownership in PGNY or FLGT? 94.9% of Progyny shares are owned by institutional investors. Comparatively, 48.1% of Fulgent Genetics shares are owned by institutional investors. 9.4% of Progyny shares are owned by company insiders. Comparatively, 31.8% of Fulgent Genetics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. SummaryProgyny beats Fulgent Genetics on 14 of the 18 factors compared between the two stocks. Get Fulgent Genetics News Delivered to You Automatically Sign up to receive the latest news and ratings for FLGT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FLGT vs. The Competition Export to ExcelMetricFulgent GeneticsMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$535.53M$2.88B$5.56B$7.83BDividend YieldN/A31.29%5.11%4.22%P/E Ratio-3.1413.2822.4418.48Price / Sales1.89188.21393.95103.59Price / Cash5.1257.5638.1834.62Price / Book0.454.676.774.25Net Income-$167.82M-$22.21M$3.22B$248.23M7 Day Performance-8.88%-1.91%1.45%0.89%1 Month Performance0.23%3.24%3.96%3.53%1 Year Performance-16.18%11.50%16.07%5.08% Fulgent Genetics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FLGTFulgent Genetics2.717 of 5 stars$17.23-0.7%$16.00-7.1%-14.7%$530.53M$283.47M-3.111,010Upcoming EarningsNews CoveragePositive NewsPGNYProgyny1.1745 of 5 stars$21.37-0.3%$23.64+10.6%-28.8%$1.83B$1.17B36.85310Upcoming EarningsPositive NewsADUSAddus HomeCare4.6955 of 5 stars$97.28-3.9%$132.78+36.5%+8.7%$1.77B$1.15B22.2633,200Upcoming EarningsPositive NewsAGLagilon health1.6716 of 5 stars$4.14+3.5%$4.60+11.0%-22.5%$1.71B$6.06B-4.40650Upcoming EarningsAnalyst ForecastNews CoverageARDTArdent Health Partners2.7412 of 5 stars$11.61-7.2%$20.58+77.3%N/A$1.66B$5.97B0.0024,200Upcoming EarningsAnalyst RevisionPositive NewsNHCNational HealthCareN/A$90.31-2.0%N/AN/A$1.40B$1.30B11.3212,400Positive NewsPACSPACS Group3.1745 of 5 stars$8.58-7.3%$34.00+296.3%-61.5%$1.31B$3.56B0.0032,433Positive NewsTDOCTeladoc Health3.817 of 5 stars$6.52-4.5%$10.82+66.0%-43.8%$1.14B$2.57B-1.135,100Analyst ForecastNews CoverageVRDNViridian Therapeutics1.2599 of 5 stars$13.13flat$35.70+171.9%+2.2%$1.07B$302,000.00-3.0550Upcoming EarningsNews CoveragePositive NewsAHCOAdaptHealth3.4486 of 5 stars$7.33-5.9%$13.80+88.3%-13.6%$988.58M$3.26B-4.4410,900Upcoming EarningsCDNACareDx3.4851 of 5 stars$16.94-3.9%$30.33+79.1%+117.5%$938.92M$333.79M-6.27740Earnings ReportNews CoverageGap Down Related Companies and Tools Related Companies PGNY Competitors ADUS Competitors AGL Competitors ARDT Competitors NHC Competitors PACS Competitors TDOC Competitors VRDN Competitors AHCO Competitors CDNA Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FLGT) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredMassive dollar overhaul underway in D.C.?Trump's plan to save the U.S. Dollar The U.S. Dollar is crashing, and our reserve currency status is now in...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fulgent Genetics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fulgent Genetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy FLGT Stock Free FLGT Stock Alerts